BioXcel Therapeutics, Inc. Payments for Restructuring
BioXcel Therapeutics, Inc. (BTAI) reported Payments for Restructuring of $194.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-13
- BioXcel Therapeutics, Inc. payments for restructuring for the quarter ending 2025-09-30 was $194.00K.
- BioXcel Therapeutics, Inc. payments for restructuring for the quarter ending 2025-06-30 was $128.00K.
- BioXcel Therapeutics, Inc. payments for restructuring for the quarter ending 2025-03-31 was $475.00K.
- BioXcel Therapeutics, Inc. payments for restructuring for the quarter ending 2024-12-31 was $983.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-09-30 | $194.00K 10-Q · filed 2026-08-13 | $322.00K derived: sum of 2 quarters · filed 2026-08-13 | $797.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.78M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $128.00K 10-K · filed 2026-03-27 | $603.00K derived: sum of 2 quarters · filed 2026-03-27 | $1.59M derived: sum of 3 quarters · filed 2026-03-27 | |
| 2025-03-31 | $475.00K 10-K · filed 2026-03-27 | $1.46M derived: sum of 2 quarters · filed 2026-03-27 | ||
| 2024-12-31 | $983.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |